MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20234470

November 14, 2023

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg,按C₂₁H₂₄FN₃O₄计)

化学药品

November 14, 2023

Company Information

Applicant Company

合肥市高新区科学大道61号

Manufacturing Company

合肥市高新区科学大道61号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath